Key Insights

Highlights

Treatment Research

2 treatments under study, led by Kidney Biopsy

Research Leaders

11 sponsors active, led by KangWon National University Hospital

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05946564Phase 3Recruiting

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

NCT03929887Recruiting

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Showing all 2 trials

Research Network

Common Treatments

  • Kidney Biopsy1
  • Pioglitazone1

Active Sponsors

  • KangWon National University Hospital1
  • Assistance Publique - Hôpitaux de Paris1
  • Chung-Ang University Hospital1
  • Seoul National University Bundang Hospital1
  • Ministry of Health & Welfare, Korea1

Top Investigators

Related Conditions

  • Focal Segmental Glomerulosclerosis1
  • Iga Nephropathy1
  • Minimal Change Disease1
  • Lupus Nephritis1
  • Rapidly Progressive Glomerulonephritis1

Activity Timeline